SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Tesla, Inc. engages in the design, development, manufacture, and sale of electric vehicles and energy generation and storage systems. It operates through the Automotive and Energy Generation and Storage segments. The Automotive segment includes the design, development, manufacture, sale, and lease of electric vehicles as well as sales of automotive regulatory credits. The Energy Generation and Storage segment is involved in the design, manufacture, installation, sale, and lease of solar energy generation, energy storage products, and related services and sales of solar energy systems incentives. The company was founded by Jeffrey B. Straubel, Elon Reeve Musk, Martin Eberhard, and Marc Tarpenning on July 1, 2003 and is headquartered in Austin, TX.

Tesla Inc

Tesla is currently facing significant selling pressure and heightened volatility as investors weigh disappointing delivery figures against the company's aggressive pivot toward AI, robotics, and the potential SpaceX IPO. The community remains deeply divided, with bears pointing to stagnating core automotive demand and leadership concerns, while bulls continue to focus on the long-term potential of the autonomous technology and energy storage sectors.

Solana is a high-performance Layer 1 blockchain designed for mass adoption by providing a fast, secure, and low-cost environment for decentralized applications. It distinguishes itself by scaling globally without the use of complex sharding or multiple layers, instead maintaining a single, unified ledger to avoid liquidity fragmentation. This architecture allows it to process thousands of transactions per second with sub-second finality, often at a cost of less than a penny per transaction.  The network operates on a unique hybrid model that combines Proof of Stake with an innovation called Proof of History, which functions as a decentralized clock to timestamp transactions. This system reduces the need for constant node communication, allowing the Sealevel engine to run non-conflicting smart contracts in parallel across multiple CPU cores. Further efficiency is gained through the Gulf Stream protocol, which reduces confirmation times by forwarding transactions to validators before the current block is finished.  Founded in 2017 by Anatoly Yakovenko, Solana is now supported by the Switzerland-based Solana Foundation and significant institutional investors like Andreessen Horowitz and Polychain Capital. The platform’s native token, SOL, serves as the primary currency for paying transaction fees, participating in network governance, and securing the system through staking.   Solana has also seen significant institutional adoption ranging from spot Solana ETFs to major partnerships including Visa's 2025 launch of USDC settlement on the network and the tokenization of public equity by firms like Galaxy Digital.

Solana

Solana is currently at the center of significant community debate as traders weigh its role as a high-speed infrastructure backbone against concerns over DeFi protocol security and broader market volatility. While some participants are capitalizing on the asset's price fluctuations and developer ecosystem growth, others are expressing caution regarding institutional sentiment and the ongoing influence of macroeconomic headwinds on the broader crypto landscape.

Enphase Energy, Inc. is a global energy technology company, which engages in the business of designing, developing, manufacturing, and selling home energy solutions that manage energy generation, energy storage, control, and communications on one intelligent platform. It operates through the following geographical segments: the United States, the Netherlands, and Others. The company was founded by Raghuveer R. Belur and Martin Fornage in March 2006 and is headquartered in Fremont, CA.

Enphase Energy Inc

Enphase Energy is rallying following a strong earnings report that beat analyst estimates for both revenue and earnings per share, signaling a potential turning point for the stock. The community is actively debating whether this movement represents a sustainable recovery for the solar sector or if it is merely a temporary bounce driven by short covering and speculative trading.

Aehr Test Systems engages in the design, manufacture, market, and sale of test and burn-in equipment used in the semiconductor industry. Its products include FOX-XP, FOX-NP, and FOX-CP wafer contact parallel test and burn-in systems, the WaferPak full wafer contactor, the DiePak Carrier, the WaferPak Aligner, the DiePak Autoloader, and test fixtures. The company was founded by Rhea J. Posedel on May 25, 1977 and is headquartered in Fremont, CA.

Aehr Test Systems

Aehr Test Systems is surging due to a major production order from a lead hyperscale customer for its high-power Sonoma testing systems, validating the company's critical role in the AI processor supply chain. The community is actively discussing the potential for a massive commercial ramp through 2027, as investors view this contract as a key inflection point that supports the company's guidance and long-term bookings outlook.

Tilray Brands, Inc. engages as a consumer packaged goods company, which focuses on medical cannabis research and the cultivation, processing, and distribution of cannabis products worldwide. It operates through the followings segments: Cannabis, Distribution, Beverage, and Wellness. The Cannabis segment focuses on cultivation, production, distribution, and sale of both medical and adult-use cannabis products. The Distribution segment is involved in purchase, resale, and distribution of pharmaceutical and wellness products. The Beverage segment refers to the production, marketing, and sale of beverages. The Wellness segment represents the production, marketing, and distribution of hemp-based food and other wellness products. The company was founded on January 24, 2018 and is headquartered in Leamington, Canada.

Tilray Brands Inc

Tilray Brands is trending as investors weigh strong Q3 revenue beats and international growth against continued concerns over management's diversification strategy and potential dilution. The community remains deeply divided, with bulls pointing to the company's evolving global medical cannabis footprint as a long-term catalyst, while vocal skeptics remain focused on historical share price declines and skepticism toward the CEO's leadership.

Investment Managers Series Trust II - Tradr 2X Long AAOI Daily ETF

The Tradr 2X Long AAOI Daily ETF

Investors are actively trading AAOX, a newly launched 2X leveraged ETF designed to amplify the daily performance of Applied Optoelectronics within the high-growth optical networking and AI sector. The community is focused on technical setups and the potential for increased volatility, while navigating the accessibility of this new leveraged instrument across various brokerage platforms.

Kelly Services, Inc. engages in the provision of talent solutions. It operates through the following segments: Professional and Industrial, Science, Engineering, and Technology, Education, Outsourcing and Consulting, and International. The Professional and Industrial segment includes the provision of administrative, accounting and finance, light industrial, contact center staffing, and other workforce solutions. The Science, Engineering, and Technology segment focuses on staffing, outcome-based, permanent placement services, clinical research, and telecommunications. The Education segment involves offering education and therapy services talent through staffing, permanent placement, and executive search services to Pre-K-12 school districts and organizations. The Outsourcing and Consulting segment consists of global talent supply chain and workforce solutions, including Managed Service Provider (MSP), Recruitment Process Outsourcing (RPO), Payroll Process Outsourcing (PPO), and executive coaching programs. The company was founded by William Russell Kelly on October 7, 1946 and is headquartered in Troy, MI.

Kelly Services, Inc. - Ordinary Shares - Class B

KELYB is trending as investors focus on its extremely low float and potential for high volatility, with the community actively monitoring upcoming earnings and conference calls as catalysts for a potential squeeze. While some participants are bullish due to significant insider buying and institutional positions, others are expressing caution, citing concerns over recent price manipulation and the stock's tendency to experience sharp, rapid moves followed by consolidation.

Replimune Group, Inc. is a clinical-stage biotechnology company. It engages in the business of developing oncolytic immunotherapies for the treatment of cancer. The company was founded by Philip Astley-Sparke, Colin A. Love, and Robert Coffin in March 2015 and is headquartered in Woburn, MA.

Replimune Group Inc

Replimune is trending as investors react to the FDA's acceptance of its BLA resubmission for RP1 in advanced melanoma, setting a PDUFA date of April 10, 2026. The community remains deeply divided, with some traders betting on a turnaround and potential short squeeze, while skeptics warn of persistent regulatory hurdles and the risk of further delays similar to the previous rejection.

Plasma is the layer 1 blockchain building the stablecoin infrastructure for a new global financial system.   It is purpose-built for global stablecoin payments, offering zero-fee USD₮ transfers and custom gas tokens to help realise the stablecoin promise of permissionless access to financial services for everyone, everywhere.   Plasma’s global payments coverage and inbound suite of products position it as the native chain for stablecoin payments.

Plasma

XPL is experiencing high volatility as investors debate whether the recent price swings and exchange listings represent a genuine utility-driven recovery or a pump-and-dump scheme. The community remains deeply divided, with some highlighting the project's stablecoin infrastructure and potential for adoption, while others express frustration over significant price declines and lack of transparency.

The 401jK (just kidding) meme is a satirical punch in the gut in the face of the concept of retirement and the popular US based 401(k) retirement plan and other pension plans around the world  Through the meme fueled humor, irony, satire &amp; inspiration from cypherpunk ideology, real life data, and current events... the 401jK community aims to comment on the fact that global markets are heavily manipulated for selfish purposes by the same people who control these pension funds... while also aiming to twist the heads of the 401k and global pension systems.  It is a retirement plan that seeks to make social, political, economic commentary fueled by the memes and dreams of the hive mind of the community that makes up 401jK  The rules have changed, and the game was always rigged.  It's time to wake up, adapt, rebel, and heal.  Welcome to 401jK

401jK

401JK is gaining momentum as a community-driven movement that leverages memes to mock the traditional retirement system and advocate for financial independence. The community is actively promoting its 'Resist and Retire' narrative through real-world raids, grassroots educational content, and a focus on long-term conviction over short-term speculation.

statis crypto Watchlist

Bitcoin

Ethereum

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Shares of Mankind Pharma fell nearly 1% on Monday after the company said it has signed a Business Transfer Agreement with its wholly owned subsidiary, Bharat Serums &amp; Vaccines (BSV), to acquire BSV’s Women’s Health Rx portfolio for ₹797 crore on a going-concern basis through a slump sale.Under the terms of the agreement, 50% of the consideration will be paid at closing, with the remaining amount due within 150 days. The deal’s completion is subject to customary preconditions and regulatory approvals.Strategic RationaleSEBI-registered investment advisor&nbsp;<a href="https://stocktwits.com/thetradebond">Nidhi Saxena</a> of The Trade Bond said the acquisition marks a consolidation in a high-growth and high-margin therapeutic segment, adding that it strategically deepens Mankind’s presence in women’s health and fertility care.<stembedurl>https://stocktwits.com/thetradebond/message/632058810</stembedurl>She noted that the transaction will give Mankind full control over branded gynecology, fertility, and obstetrics products, including market rights, distribution, and brand IP — while integrating the portfolio into its core prescription business.Why It MattersAccording to Saxena, the move could help Mankind leverage its large salesforce for cross-selling, expand its specialty portfolio, and improve profitability. Women’s health, she said, is growing faster than India’s broader pharmaceutical market, making this a timely strategic bet.“This is not just an acquisition — it’s Mankind strengthening its identity as a serious specialty pharma player,” Saxena said, adding that if integration is smooth, the deal could prove earnings accretive and trigger a valuation re-rating in the medium term.Risks And ExecutionSaxena, however, warned that not all the operations under the new portfolio could be integrated with Mankind’s existing business right away. Some potential challenges, she cited, include brand management, approvals, and ensuring continuity of the trust that the operations enjoy with doctors and patients.&nbsp;She added that the next six to twelve months will be crucial in determining whether the ₹797 crore invested is indeed translating into value.That said, she is optimistic about medium-term benefits if Mankind executes well. She said that, at that point, it could support margins and help attract more institutional investors as the benefits start to get reflected on the earnings front.What Is The Retail Mood?On Stocktwits, retail sentiment was ‘bullish’ amid ‘high’ message volume.<a href="https://stocktwits.com/symbol/MANKIND.NSE">Mankind Pharma’s stock</a> has declined 15% so far in 2025.For updates and corrections, email newsroom[at]stocktwits[dot]com.

Mankind Pharma Strengthens Specialty Segment With ₹797 Crore BSV Deal

The analyst cautioned that smooth integration and execution over the next year will be key to unlocking its full value.

Equity

Indian equity markets are set for a cautious opening on Monday, with the Gift Nifty, an early indicator for the Nifty 50 index, climbing 0.4% higher.&nbsp;The escalating trade tensions between US and China weighed on global market sentiment with all major Asian markets were down on Monday, with the bourses in Hong Kong and Thailand falling more than 2% each.At the time of writing, the gold spot price gained 1.6% to reclaim the key $4,000 mark. It was trading at $4,049.57&nbsp;per ounce. Brent crude traded up 1.6% at $63.74&nbsp;per barrel.Stock WatchLupin: The USFDA completed a pre-approval inspection at its Somerset, New Jersey plant with one observation.Kotak Mahindra Bank: Sonata Finance has merged with BSS Microfinance and ceased to be a subsidiary of Kotak Bank, effective October 11.Tata Motors: Last day to buy consolidated stock ahead of demerger on October 14.Mahindra Lifespace Developers: Selected for a ₹800 crore redevelopment project in Mumbai’s Malad and acquired 13.46 acres in Pune with a ₹3,500 crore potential.Hindustan Construction Company: Won a ₹204 crore order from Hindalco for fabrication and erection work at its Aditya Aluminium expansion in Odisha.Sanofi Consumer Healthcare India: CFO Narahari Naidu resigned.Travel Food Services: Subsidiary TFS Gurgaon Airport Services signed a license agreement with Delhi Airport to manage F&amp;B outlets at Terminal 2.Mankind Pharma: Entered a ₹797 crore slump sale deal with Bharat Serums and Vaccines to acquire its women’s health Rx portfolio.NTPC Green Energy: Signed an MoU with Japan’s ENEOS Corporation to supply green methanol and hydrogen-based products.Allied Blenders and Distillers: Appointed Jayant Bhalchandra Manmadkar as Chief Financial Officer effective October 10.Infosys: Launched the Infosys Customer Experience Suite for Salesforce to enhance enterprise digital transformation and Agentforce solutions.Zen Technologies: Secured a ₹37 crore defence order for anti-drone systems with Hard Kill capability.Asian Paints: Subsidiary Asian White Inc. FZE began commercial production at its white cement plant in Fujairah, UAE, with a capacity of 2.65 lakh tons per annum.Axis Bank: The RBI issued a ‘Letter of Caution’ regarding KYC compliance; the bank stated that corrective steps are already in place.Computer Age Management Services (CAMS): Board approved a stock split in the ratio of 1:5, reducing the face value per share from ₹10 to ₹2, subject to shareholder approval.EarningsAvenue Supermarts (DMart): DMart’s Q2 consolidated net profit rose 3.9% to ₹684.85 crore, while revenue grew 15.5% to ₹16,676.3 crore. EBITDA climbed 11% to ₹1,213.65 crore, though margins slipped 29 bps to 7.28%.Waaree Renewable Technologies: Q2 Profit surged 117.4% to ₹116.3 crore, driven by a 47.7% jump in revenue to ₹774.8 crore.Signature Global: Q2 pre-sales fell 28% to ₹2,010 crore and area sold dropped 44% to 1.34 million sq. ft, while collections rose slightly by 2% to ₹940 crore.Adani Energy Solutions: The transmission order book stands at ₹60,004 crore across 13 projects.Phoenix Mills: Q2 retail consumption across malls increased 13%, residential sales rose to ₹139 crore from ₹27 crore, and collections nearly doubled to ₹115 crore.Bajaj Finserv: Bajaj Life Insurance reported total premiums of ₹1,374.6 crore, while Bajaj General Insurance’s gross direct premium reached ₹2,218.8 crore.Q2 Results TodayHCL Technologies, Anand Rathi Wealth, Den Networks, Just Dial, Lotus Chocolate Company, and Stallion India FluorochemicalsActive IPOsRubicon Research, Canara Robeco AMC, Canara HSBC Life InsuranceListing TodayTata CapitalFor updates and corrections, email newsroom[at]stocktwits[dot]com.&nbsp;

The digital broadcast on the facade of the Bombay Stock Exchange (BSE) displays the benchmark share index SENSEX crossing 32,000 points, on July 13, 2017 in Mumbai, India. (Photo by Kunal Patil/Hindustan Times via Getty Images)

Sensex, Nifty Poised For A Cautious Opening; HCL Tech, Tata Motors, DMart, Waaree, Mahindra Lifespace, NTPC Green Stocks Are In Focus

Tata Capital to list on NSE and BSE today. The grey market premium suggests a lacklustre debut for India’s largest IPO

Sensex, Nifty Poised For A Strong Opening; HCL Tech, Tata Motors, DMart, Waaree, Mahindra Lifespace, NTPC Green Stocks Are In Focus

Indian equity markets continue to trade rangebound as global trade tensions, sustained FII outflows, and subdued earnings season weighed on investor sentiment.&nbsp;SEBI-registered analysts&nbsp;<a href="https://stocktwits.com/Vinaytaparia">Vinay Taparia</a> and&nbsp;<a href="https://stocktwits.com/Wisebull_co_in">Vinayak Gautam</a> have identified select stocks based on their technical strength or breakout potential.Let’s take a look at Taparia’s stock recommendations:Diamines &amp; Chemicals<a href="https://stocktwits.com/symbol/DIAMINESQ.NSE">Diamines&nbsp;</a>has given a small breakout with good volume. The stock can move to ₹460-₹510 levels in next six to nine months, but a close below ₹365 negates this view.<stembedurl>https://stocktwits.com/Vinaytaparia/message/623886820</stembedurl>Gujarat Narmada Valley Fertilizers &amp; Chemicals (GNFC)<a href="https://stocktwits.com/symbol/GNFC.NSE">GNFC</a> is consolidating above the upward moving trendline.The stock can move to ₹580-₹620 level in next six to nine months, but a close below ₹520 would invalidate this outlook.<stembedurl>https://stocktwits.com/Vinaytaparia/message/623888872</stembedurl>R Systems International&nbsp;<a href="https://stocktwits.com/symbol/RSYSTEMS.NSE">R Systems</a> has given a good breakout after a few days of down trend. The stock can move to ₹480-₹500 level in next six months. A close below ₹405 negates this view.<stembedurl>https://stocktwits.com/Vinaytaparia/message/623889185</stembedurl>Meanwhile, analyst Vinayak Gautam has identified three stocks with a one-week trading timeframe.&nbsp;<a href="https://stocktwits.com/symbol/MANKIND.NSE">Mankind Pharma</a>: One can buy this stock at&nbsp;₹2,553, with a target price of ₹2,750 for a stop loss at ₹2,490.<a href="https://stocktwits.com/symbol/DATAMATICS.NSE">Datamatics</a>:&nbsp;One can buy this stock at&nbsp;₹1,050, with a target price of ₹1,080 for a stop loss at ₹1,035.<a href="https://stocktwits.com/symbol/WAAREEENER.NSE">Waaree Energies</a>:&nbsp;One can buy this stock at&nbsp;₹3,218, with a target price of ₹3,400 for a stop loss at ₹3,110.<stembedurl>https://stocktwits.com/Wisebull_co_in/message/624064276</stembedurl>For updates and corrections, email newsroom[at]stocktwits[dot]com.

Rising stock market chart on a trading board background.

Trade Ideas From SEBI Analysts: Six Stocks That Investors Can Add To Their Watchlist 

GNFC, Mankind Pharma, Waaree Energies, and three other stocks are trending on analysts’ radar. 

Indian equity markets closed lower on Thursday, dragged down by stocks in the&nbsp;energy, pharmaceutical, and other sectors. The benchmark indices began on a weak note after U.S. President Donald Trump announced a 25% tariff on Indian goods. Despite making a mid-session recovery, the Nifty index failed to hold above 24,800.Markets are&nbsp;expected to open&nbsp;muted on Friday, tracking broader global cues. Trump confirmed the tariff rates for U.S. trading partners through an executive order signed on Thursday. As announced by a Truth Social post on Thursday, India was hit with a 25% levy.The Gift Nifty, an early indicator of the Nifty 50, reversed early session losses to climb 0.16% higher at 24,745&nbsp;as of 8:45 am IST.Here are the stocks to watch out for heading into today’s session.Results Today&nbsp;&nbsp;ABB India, AJAX Engineering, Balaji Amines, Federal Bank, Finolex Industries, Medplus Health Services, Utkarsh Small Finance Bank,&nbsp;ITC, Godrej Properties, Tata Power, LIC Housing, Delhivery, Adani Power, and MCX.&nbsp;Earnings ImpactEicher Motors: Posted a 9.4% rise in Q1 profit to ₹1,205.2 crore, with revenue up 14.8% at ₹5,041.8 crore.Coal India: Reported a 20.2% drop in Q1 profit to ₹8,734.2 crore and a 4.4% decline in revenue, while announcing a ₹5.5 interim dividend for FY26.Swiggy: Q1 loss widened to ₹1,197 crore, even as revenue surged 54% to ₹4,961 crore, driven by strong growth in quick commerce and supply chain businesses.PB Fintech: Clocked a 40.6% rise in Q1 profit to ₹84.6 crore and a 33.4% increase in revenue to ₹1,348 crore.Chalet Hotels: Reported a 235% surge in Q1 profit to ₹203.2 crore and a 147.8% jump in revenue to ₹894.6 crore.Chambal Fertilisers &amp; Chemicals: Posted a 22.4% profit growth to ₹548.9 crore in Q1, with revenue rising 15.5% to ₹5,697.6 crore.City Union Bank: Reported a 15.7% profit rise to ₹305.9 crore in Q1 and improved asset quality with lower GNPA and NNPA ratios.Neuland Laboratories: Reported an 85.8% decline in Q1 profit to ₹13.9 crore, with revenue falling 33.4% to ₹292.8 crore.Thermax: Recorded a 38.4% increase in Q1 profit to ₹151.5 crore, while revenue dipped 1.6% to ₹2,150.2 crore.TeamLease Services: Saw a 27.7% growth in Q1 profit to ₹26.5 crore and a 12.1% rise in revenue to ₹2,891.4 crore.TCPL Packaging: Posted a 29.6% fall in Q1 profit to ₹22.3 crore despite a 4.7% revenue increase to ₹424.7 crore.Restaurant Brands Asia: Q1 loss narrowed to ₹41.9 crore, with revenue rising 7.9% to ₹697.7 crore.Timken India: Reported an 8.2% increase in Q1 profit to ₹104.2 crore and a 3.2% rise in revenue to ₹808.8 crore.Barbeque Nation Hospitality: Q1 loss widened to ₹16.4 crore, with revenue declining 2.8% to ₹297 crore.RR Kabel: Posted a 39.4% jump in Q1 profit to ₹89.8 crore, with revenue growing 13.9% to ₹2,058.6 crore.Sanofi India: Reported a 32.8% decline in Q2 profit to ₹69.5 crore, with revenue down 12.3% at ₹406.3 crore.Great Eastern Shipping Company: Q1 profit fell 37.9% to ₹504.5 crore and revenue dropped 20.3% to ₹1,201.5 crore.JSW Energy: Posted a 42.4% increase in Q1 profit to ₹743.1 crore, with revenue jumping 78.6% to ₹5,143.4 crore.Aarti Industries: Reported a 68.6% slump in Q1 profit to ₹43 crore and a 9.5% drop in revenue to ₹1,676 crore.Mankind Pharma: Posted an 18.1% decline in Q1 profit to ₹444.6 crore, even as revenue rose 24.5% to ₹3,570.4 crore.Sundram Fasteners: Recorded a 4.6% rise in Q1 profit to ₹148.4 crore and a 2.4% increase in revenue to ₹1,533.4 crore.Indegene: Q1 profit jumped 32.7% to ₹116.4 crore, with revenue up 12.5% at ₹760.8 crore.Niva Bupa Health Insurance: Posted a sharply wider Q1 loss of ₹91.44 crore, despite double-digit growth in gross and net premiums.Stocks To WatchGujarat Gas: Signed a Gas Sales Agreement with Waree Energy to supply 50,000 SCMD of PNG to a lithium-ion cell plant in Valsad, set to be commissioned in Q4 FY26.Deepak Nitrite: Subsidiary Deepak Chem Tech has issued ₹50 crore worth of 9% OCRPS to the parent company.RPP Infra Projects: Secured a ₹1.43 crore order for elevator supply and installation at NNTPS, including civil and electrical work.PNB Housing Finance: MD &amp; CEO Girish Kousgi has resigned,&nbsp;effective Oct. 28, 2025.NCC: Received two orders worth ₹792 crore in July, with ₹461.39 crore for its Buildings Division and ₹330.15 crore for its Electrical Division.NBCC: Signed a ₹45.3 crore agreement with Madhya Pradesh Gramin Bank for a new campus in Indore and another with the Department of Posts for nationwide land development.Nestle: Announced that Chairman and MD Suresh Narayanan will retire effective July 31, 2025.Tata Steel: Set to acquire a 40% stake in TSN Wires Co. from Nichia Steel Works Ltd. for ₹270 crore.Equitas Small Finance Bank: Allotted 50,000 non-convertible debentures worth ₹500 crore via private placement.Bank of India: To cut 1-year MCLR by 10 basis points to 8.9% starting Friday.Arihant Superstructures: GST search and seizure operation on the company and its unit, Vatika Realty.&nbsp;For updates and corrections, email newsroom[at]stocktwits[dot]com.

Trading Radar For August 1: Trump Tariffs Kick In; Auto Stocks, Coal India, Gujarat Gas On Stock Watchlist

ABB India, ITC, Adani Power, and Federal Bank are among the companies reporting quarterly results later in the day.

Several stocks are flashing bullish technical patterns this week. In an ‘Ask Me Anything’ (AMA) session held on July 16 on Stocktwits, SEBI-registered analyst Mayank Singh Chandel shared his trading strategies on stocks across the large-cap spectrum.&nbsp;Let’s take a look at his recommendations:&nbsp;L&amp;T Finance<a href="https://stocktwits.com/symbol/LTF.NSE">L&amp;T Finance</a> is in an uptrend and holding above its 50-day Exponential Moving Average (EMA), showing strength. However, it's better to wait for a pullback before entering. Chandel flagged an ideal entry zone between ₹198 and ₹194.<stembedurl>https://stocktwits.com/Ca_mscofficial/message/621106274</stembedurl>BHEL<a href="https://stocktwits.com/symbol/BHEL.NSE">BHEL</a> is in a strong uptrend, and after a healthy pullback, it has resumed its upward move. Since May 2025, it’s been consolidating. Aggressive traders may enter at current levels, while conservative traders can wait for a close above ₹270.<stembedurl>https://stocktwits.com/Ca_mscofficial/message/621106149</stembedurl>Vodafone Idea&nbsp;<a href="https://stocktwits.com/symbol/IDEA.NSE">Idea</a> has a bearish structure and has corrected nearly 60% from its June 2025 high. Given the weak trend, it's better to avoid the stock for now.<stembedurl>https://stocktwits.com/Ca_mscofficial/message/621180705</stembedurl>IDFC First Bank<a href="https://stocktwits.com/symbol/IDFCFIRSTB.NSE">IDFC First Bank</a> has taken support near ₹52, a previous resistance level that has now become support, and has broken its downward trendline. Since April 2025, it has been forming higher highs and higher lows, and the next target could be around ₹95.<stembedurl>https://stocktwits.com/Ca_mscofficial/message/621118245</stembedurl>Samvardhana Motherson<a href="https://stocktwits.com/symbol/MOTHERSON.NSE">Samvardhana Motherson</a> is in an uptrend, but it tends to exhibit significant price swings, which can be challenging for traders. Despite the volatility, the overall bias remains bullish.<stembedurl>https://stocktwits.com/Ca_mscofficial/message/621108192</stembedurl>Mankind Pharma&nbsp;<a href="https://stocktwits.com/symbol/MANKIND.NSE">Mankind Pharma</a> has been in an uptrend since listing, with every pullback followed by a strong rally. It has recently broken its previous swing high and is now testing that level, making it a potential buying zone.<stembedurl>https://stocktwits.com/Ca_mscofficial/message/621111105</stembedurl>ITC Hotels&nbsp;Chandel said that&nbsp;<a href="https://stocktwits.com/symbol/ITCHOTELS.NSE">ITC Hotels</a> has seen a steady uptrend with higher highs and higher lows since its listing, and is also trading above its 50-day EMA, which indicates strong short-term momentum. Backed by solid fundamentals, including ITC’s 105% YoY profit growth in March 2025, the overall outlook remains positive.<stembedurl>https://stocktwits.com/Ca_mscofficial/message/621106005</stembedurl>Eternal (Zomato)<a href="https://stocktwits.com/symbol/ETERNAL.NSE">Eternal</a> has been in an uptrend since early 2023 and has resumed its rally after a healthy pullback, now trading above its 50-day EMA. Any dip towards the 50-day EMA could offer a good entry point. The short-term target is ₹300, and for long term, the trend can be ridden with a stoploss below the 50 EMA.<stembedurl>https://stocktwits.com/Ca_mscofficial/message/621182410</stembedurl>For updates and corrections, email newsroom[at]stocktwits[dot]com.

Representative image of a stock chart on black background. | Image source: Getty Images

From L&T Finance To Eternal: SEBI RA Maps Entry Strategies In Trending Stocks

The analyst identifies strong setups in L&T Finance, IDFC First Bank, and Eternal, while maintaining caution on names such as Vodafone Idea.

In range-bound markets, technical structures can offer much-needed clarity. Stocks trading near the bottom of their regression channels often signal turning points. SEBI-registered analyst Rajneesh Sharma highlights three stocks that appear to be at key inflection zones.<stembedurl>https://stocktwits.com/Rajneesh_Sharma_Official/message/620147844</stembedurl>Mankind PharmaMankind Pharma has been moving within a broad ascending channel since early 2023, marked by consistently hitting higher highs and higher lows, <a href="https://stocktwits.com/Rajneesh_Sharma_Official">Sharma</a> said.The stock is now nearing the lower end of this channel, which aligns closely with support at ₹2,295, a level that has acted as resistance in July 2023 and February 2024 and as support in May and July 2025.Recent price action has shown hesitation near support, as small-bodied candles with long wicks indicate possible accumulation, Sharma said. Although there hasn’t been a clear bullish reversal yet, the lack of a breakdown is a positive signal.A close below ₹2,295 could challenge the trend structure, but holding above it may lead to a rebound toward the ₹2,600 - ₹2,800 resistance zone, a 10.6% premium to the current trading price of ₹2,534.70.At the time of writing, <a href="https://stocktwits.com/symbol/MANKIND.NSE">Mankind Pharma stock</a> is up 4.2%, having lost over 12% year-to-date (YTD).Danish PowerDanish Power continues to trade within a disciplined rising channel. The recent correction brought the stock down to a key horizontal support at ₹1,041.05, which aligns with the mid-to-lower section of the trend channel, the analyst noted.The ₹1,041 level has served as a pivot since April, and the stock has shown respect for the trend channel, despite occasional volatility. However, volume remains muted, which should make traders cautious, he added.As long as the price remains above ₹1,041, the uptrend remains valid, and a move above ₹1,080 could lead to a test of the ₹1,186 zone, representing a 10% upside.At the time of writing, <a href="https://stocktwits.com/symbol/DANISH.NSE">Danish Power shares</a> were up 2% to ₹1,057. It has shed more than 5% YTD.Everest Kanto CylinderEverest Kanto is currently testing a multi-year rising trendline from mid-2020, while a bullish divergence on the weekly Relative Strength Index (RSI), an early signal of trend reversal.Momentum appears to be stabilizing, with the weekly RSI crossing above the 50 mark, indicating a strong upside potential. The price is hovering near the minor resistance at ₹145, and a breakout above ₹150 could confirm a shift in trend.If the stock fails to hold the trendline, however, ₹115 would be the final technical support before the risk of a deeper pullback.<a href="https://stocktwits.com/symbol/EKC.NSE">Everest Kanto shares</a> were trading 0.6% lower at ₹142.21, with YTD losses at 23.30%.For updates and corrections, email newsroom[at]stocktwits[dot]com.&nbsp;

(Photo credit should read INDRANIL MUKHERJEE/AFP via Getty Images)

Technical Radar: These Three Stocks Are Approaching Make-Or-Break Level, Says SEBI RA Rajneesh Sharma 

Mankind Pharma, Danish Power and Everest Kanto have seen heavy selling pressure in 2025, but technical indicators signal bearish exhaustion

Mankind Pharma Ltd. engages in the development, manufacture, and marketing of pharmaceutical formulations across acute and chronic therapeutic areas. It offers products under the brands of Nurokind, Telmikind, Manforce, Unwanted, Gudcef, Moxikind, Amlokind, Glimestar, Asthakind, Codistar, Candiforce, Mahacef, Prega News, Dydroboon, Cefakind, Monticope, and Caldikind. The company was founded by Ramesh Chand Juneja in 1986 and is headquartered in New Delhi, India.

Fiscal Period	Estimated	Reported	Surprise	Result
Q4 '25	11.55	--	--	N/A
Q3 '25	12.25	--	--	N/A
Q2 '25	12.71	12.50	-1.69%	MISSED
Q1 '25	10.92	10.70	-1.98%	MISSED
Q4 '24	9.87	--	--	N/A

MANKIND.NSE
Mankind Pharma Ltd.

Feed

News

Sentiment

Earnings

Fundamentals

Info

Upcoming Earnings: Q4 '25

Historical Earnings

Latest MANKIND.NSE News

MANKIND.NSEMankind Pharma Ltd.